Immunophenotype Predicts Survival Time in Dogs with Chronic Lymphocytic Leukemia

Journal of Veterinary Internal Medicine

Volumn 25, Issue 1, 2011, Pages 100-106

  Comazzi, S ^a   Gelain, M E ^a   Martini, V ^a   Riondato, F ^b   Miniscalco, B ^b   Marconato, L ^c   Stefanello, D ^a   Mortarino, M ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c Animal Oncology and Imaging Center   (Switzerland)

Author keywords

Blood; Canine; Lymphoproliferative disorders; Oncology; Prognosis

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; DOG; DOG DISEASE; FLOW CYTOMETRY; IMMUNOLOGY; IMMUNOPHENOTYPING; KAPLAN MEIER METHOD; METHODOLOGY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY;

ANIMALS; DOG DISEASES; DOGS; FLOW CYTOMETRY; IMMUNOPHENOTYPING; KAPLAN-MEIER ESTIMATE; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES;

CANIS FAMILIARIS;

EID: 78651235340     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2010.0640.x     Document Type: Article

References (24)

1. Leifer CE, Matus RE. Chronic lymphocytic leukemia in the dog: 22 cases (1974-1984). J Am Vet Med Assoc 1986;189:214-217.
2. Vernau W, Moore PF. An immunophenotypic study of canine leukemias and preliminary assessment of clonality by polymerase chain reaction. Vet Immunol Immunopathol 1999;69:145-164.
3. Tasca S, Carli E, Caldin M, et al. LS Hematologic abnormalities and flow cytometric immunophenotyping results in dogs with hematopoietic neoplasia: 210 cases (2002-2006). Vet Clin Pathol 2009;38:2-12.
4. Adam F, Villiers E, Watson S, et al. Clinical pathological and epidemiological assessment of morphologically and immunologically confirmed canine leukaemia. Vet Comp Oncol 2009;7:181-195.
5. Harvey JW, Terrell TG, Hyde DM, et al. Well-differentiated lymphocytic leukemia in a dog: Long-term survival without therapy. Vet Pathol 1981;18:37-47.
6. Fujino Y, Sawamura S, Kurakawa N, et al. Treatment of chronic lymphocytic leukaemia in three dogs with melphalan and prednisolone. J Small Anim Pract 2004;45:298-303.
7. Rai KR, Sawitsky A. A review of the prognostic role of cytogenetic, phenotypic, morphologic, and immune function characteristics in chronic lymphocytic leukemia. Blood Cells 1987;12:327-338.
8. Binet JL, Auquier A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981;48:198-206.
9. Breen M, Modiano JF. Evolutionarily conserved cytogenetic changes in hematological malignancies of dogs and humans-man and his best friend share more than companionship. Chromosome Res 2008;16:145-154.
10. Hoyer JD, Ross CW, Li CY, et al. True T-cell chronic lymphocytic leukemia: A morphologic and immunophenotypic study of 25 cases. Blood 1995;86:1163-1169.
11. Workman HC, Vernau W. Chronic lymphocytic leukemia in dogs and cats: The veterinary perspective. Vet Clin North Am Small Anim Pract 2003;33:1379-1399.
12. Williams MJ, Avery AC, Lana SE, et al. Canine lymphoproliferative disease characterized by lymphocytosis: Immunophenotypic markers of prognosis. J Vet Intern Med 2008;22:596-601.
13. Botsch V, Küchenhoff H, Hartmann K, et al. Retrospective study of 871 dogs with thrombocytopenia. Vet Rec 2009;164:647-651.
14. Comazzi S, Gelain ME, Spagnolo V, et al. Flow cytometric patterns in blood from dogs with non-neoplastic and neoplastic hematologic diseases using double labeling for CD18 and CD45. Vet Clin Pathol 2006;35:47-54.
15. Fournel-Fleury C, Magnol JP, Bricaire P, et al. Cytohistological and immunological classification of canine malignant lymphomas: Comparison with human non-Hodgkin's lymphomas. J Comp Pathol 1997;117:35-59.
16. Ponce F, Marchal JP, Turinelli V, et al. A morphological study of 608 cases of canine malignant lymphoma in France with a focus on comparative similarities between canine and human lymphoma morphology. Vet Pathol 2010;47:414-433.
17. Jacobs RM, Messick JB, Valli VE. Tumors of the hemolymphatic system. In: Meuten DJ., ed. Tumors in Domestic Animals, 4th ed. Ames, IA: Iowa State Press; 2002:177-180.
18. Vail DM, Young KM. Haematopoietic tumors. In: Withrow SJ, Vail DM, eds. Withrow and Mac Ewen's Small Animal Clinical Oncology. St Louis, MO: Saunders; 2007:722-725.
19. Vallespí T, Montserrat E, Sanz MA. Chronic lymphocytic leukaemia: Prognostic value of lymphocyte morphological subtypes. A multivariate survival analysis in 146 patients. Br J Haematol 1991;77:478-485.
20. Helfand SC, Modiano JF. Chronic lymphocytic leukemia. In: Feldman BF, Zinkl JG, Jain NC, eds. Schalm's Veterinary Hematology, 5th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2000:638-641.
21. Tsimberidou AM, Keating MJ. Richter syndrome: Biology, incidence, and therapeutic strategies. Cancer 2005;103:216-228.
22. Rossi D, Gaidano G. Richter syndrome: Molecular insights and clinical perspectives. Hematol Oncol 2009;27:1-10.
23. Vroblová V, Smolej L, Vrbackỳ F, et al. Biological prognostic markers in chronic lymphocytic leukemia. Acta Medica (Hradec Kralove) 2009;52:3-8.
24. Rossi D, Lobetti Bodoni C, Genuardi E, et al. Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia. Leukemia 2009;23:1062-1072.